bioAffinity
  • Home
  • Publications
  • News
  • About
  • Contact
  • Investor Relations
Select Page
  • Home
  • Publications
  • News
  • About
  • Contact
  • Investor Relations

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Board Diversity
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
Sep 14, 2021 11:00am EDT

bioAffinity Technologies Announces Precision Pathology Services’ Validation of Novel Non-Invasive Early Lung Cancer Test

Aug 12, 2021 11:00am EDT

bioAffinity Technologies Publishes Sputum Processing and Innovative High-Throughput Analysis Methods

Jun 23, 2021 11:00am EDT

bioAffinity Technologies Presents Scientific Discoveries Advancing Cancer Therapeutics and Diagnostics at Two Global Conferences

Mar 03, 2021 11:00am EST

Leading Cell Biology Journal Publishes bioAffinity Technologies’ Groundbreaking Research on Porphyrins

Feb 04, 2021 10:00am EST

bioAffinity Technologies Executes Agreement with Fosun Long March to Evaluate CyPath® Lung for Commercialization in China

Nov 10, 2020 11:00am EST

bioAffinity Technologies to Present at 2020 American Society of Cell Biology Meeting

Oct 22, 2020 10:00am EDT

bioAffinity Technologies to Present Poster at World Conference on Lung Cancer 2020

Oct 15, 2020 10:00am EDT

Smiths Medical and bioAffinity Technologies Partner to Advance Non-Invasive Testing for Early Lung Cancer

Sep 29, 2020 11:00am EDT

bioAffinity Technologies Announces Dr. Martin Tammemägi to Chair Scientific and Medical Advisory Board

Aug 12, 2020 10:00am EDT

Precision Pathology Services and bioAffinity Technologies Announce Initiation of CLIA Validation for Non-Invasive Early Lung Cancer Test

  • arrow_back
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • arrow_forward
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed


Phone

(210) 698-5334



Email

info@bioaffinitytech.com



LinkedIn

…/bioaffinitytechnologies



Twitter

@bioAffinity

Subscribe for News from bioAffinity Technologies

Subscribe
Copyright © 2023 bioAffinity Technologies, Inc.